Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy Leave a Comment / Publications / By admin
Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Patients With Neovascular Age-Related Macular Degeneration: Studies in Japan and the United States Leave a Comment / Publications / By admin
Natural history of diabetic macular edema and factors predicting outcomes in sham-treated patients (MEAD study) Leave a Comment / Publications / By admin
Intravitreal sirolimus for persistent, exudative age-related macular degeneration: a Pilot Study Leave a Comment / Publications / By admin
Pneumatic Vitreolysis with Perfluoropropane for Vitreomacular Traction with and without Macular Hole: DRCR Retina Network Protocols AG and AH Leave a Comment / Publications / By admin
Phase 1 Study of THR-687, a Novel, Highly Potent Integrin Antagonist for the Treatment of Diabetic Macular Edema Leave a Comment / Publications / By admin
Intravitreal sirolimus with adjunct aflibercept versus aflibercept monotherapy for persistent, exudative age-related macular degeneration: a pilot study Leave a Comment / Publications / By admin
Multifocal Electroretinographic Evaluation of Long-term Hydroxychloroquine Users Leave a Comment / Publications / By admin
Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema Leave a Comment / Publications / By admin
Effect of Intravitreous Anti–Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy Leave a Comment / Publications / By admin
Clinic: 
10300 N Illinois St., Suite 1060, Carmel, IN 46290